ARMI will present at TERMIS 2025, highlighting cutting-edge regenerative medicine research and its role in scaling biomanufacturing through national collaboration.
BioFabUSA will exhibit and present at DMC 2025, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
ARMI sponsors Rockwell Automation Fair 2025 to explore smart manufacturing technologies and digital transformation in biomanufacturing and regenerative medicine.
ARMI | BioFabUSA is partnering with Phacilitate for Advanced Therapies Week 2026 in San Diego — connecting members with global leaders in cell and gene therapy manufacturing. Members can reach out to their Account Manager for an exclusive registration discount.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
